文献速递认知障碍与痴呆

血浆与脑脊液神经丝轻链:与纵向神经影像及认知指标的关系

Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures.
PubMed 文献 · Neurology · 2019-06-10

结果显示基线血浆NfL升高可预测认知下降和神经变性影像指标的恶化,效应量与脑脊液NfL相似;血浆NfL变化与短期认知变化相关。

要点

  • 基线血浆NfL升高预示认知下降及神经变性影像指标恶化,效应量与脑脊液NfL相似。
  • 血浆NfL变化与整体认知、注意力和淀粉样PET变化相关。
  • 横断面未发现血浆或脑脊液NfL与任何神经影像或认知指标相关。

核心结论

  • 基线血浆NfL升高是无痴呆老年人认知下降和神经变性影像指标恶化的预后标志物,效应量与基线脑脊液NfL相似;血浆NfL变化也追踪短期认知变化。

研究设计与样本

  • 血浆NfL用Simoa-HD1平台测量,脑脊液NfL用in-house ELISA测量;线性混合效应模型分析基线NfL与结局的关联(校正年龄、性别、教育),线性回归评估NfL变化与结局变化的关系。

主要发现

  • 横断面分析未发现脑脊液或血浆NfL与任何神经影像或认知指标存在关联。
  • 纵向分析中,较高的基线血浆NfL与除淀粉样PET外所有神经影像指标及整体认知的恶化相关。
  • 较高的基线脑脊液NfL与皮层厚度和扩散MRI的恶化相关,其β估计值与血浆NfL相似。
  • 血浆NfL变化与整体认知、注意力及淀粉样PET的变化相关。

临床怎么用

  • 血浆NfL可作为无痴呆老年人认知下降和神经变性的预后监测指标,其纵向变化有助于追踪短期认知变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to (1) assess and compare baseline plasma and CSF neurofilament light (NfL) for cross-sectional and longitudinal associations with neuroimaging or cognition and (2) determine whether change in plasma NfL corresponded with change in these outcomes. METHODS: Seventy-nine participants without dementia, median age 76 years, had plasma and CSF NfL, neuropsychological testing, and neuroimaging (MRI, amyloid PET, FDG-PET) at the same study visit, and a repeat visit (15 or 30 months later) with both plasma NfL and neuroimaging. Plasma NfL was measured on the Simoa-HD1 Platform and CSF NfL with an in-house ELISA. Linear mixed effects models were used to examine the associations between baseline plasma or CSF NfL and cognitive and neuroimaging outcomes adjusting for age, sex, and education. The relationship between change in plasma NfL and change in the outcomes was assessed using linear regression. RESULTS: There were no cross-sectional associations between CSF or plasma NfL and any neuroimaging or cognitive measure. Longitudinally, higher baseline plasma NfL was associated with worsening in all neuroimaging measures, except amyloid PET, and global cognition. Higher baseline CSF NfL was associated with worsening in cortical thickness and diffusion MRI. The beta estimates for CSF NfL were similar to those for plasma NfL. Change in plasma NfL was associated with change in global cognition, attention, and amyloid PET. CONCLUSION: Elevated baseline plasma NfL is a prognostic marker of cognitive decline and neuroimaging measures of neurodegeneration, and has similar effect sizes to baseline CSF NfL. Change in plasma NfL also tracked with short-term cognitive change.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Mielke MM, Syrjanen JA, Blennow K, et al. Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures. Neurology. 2019. PMID: 31182505. doi:10.1212/WNL.0000000000007767

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。